Lung India
Scope & Guideline
Exploring innovations in pulmonary medicine.
Introduction
Aims and Scopes
- Clinical Research in Respiratory Diseases:
The journal publishes original research articles focused on various respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and COVID-19. This research often involves clinical trials, observational studies, and case reports that contribute to the understanding of disease mechanisms and patient care. - Innovative Diagnostic Techniques:
Lung India emphasizes the importance of novel diagnostic methodologies, such as endobronchial ultrasound, imaging techniques, and biomarkers, to improve the accuracy of lung disease diagnosis and management. - Public Health and Epidemiology:
The journal addresses public health issues related to lung diseases, including the epidemiology of respiratory conditions in specific populations, the impact of environmental factors, and strategies for disease prevention and health promotion. - Management Guidelines and Consensus Statements:
The publication frequently features guidelines and consensus statements developed by expert panels to standardize treatment approaches for various lung diseases, ensuring that clinicians have access to the latest recommendations. - Interventional Pulmonology:
Research related to minimally invasive procedures and therapies in pulmonary medicine, including bronchoscopy and thoracoscopy, is a key area of focus, highlighting advancements in patient care.
Trending and Emerging
- COVID-19 Research and Sequelae:
The impact of COVID-19 on lung health has become a dominant theme, with numerous studies addressing acute management, long-term sequelae, and the implications for patients with pre-existing respiratory conditions. - Telemedicine and Remote Monitoring:
The rise of telemedicine as a vital tool for managing respiratory diseases has gained traction, particularly during the pandemic, leading to increased research on its effectiveness and implementation in clinical practice. - Personalized and Precision Medicine:
There is a growing interest in personalized treatment approaches for respiratory diseases, focusing on biomarkers and genetic factors that influence treatment responses, especially in conditions like asthma and COPD. - Management of Drug-Resistant Tuberculosis:
Research on innovative strategies and therapies for managing drug-resistant tuberculosis has increased, reflecting the urgent need to address this global health challenge. - Environmental and Occupational Lung Diseases:
Emerging studies focus on the relationship between environmental exposures, such as air pollution, and lung diseases, emphasizing the need for public health interventions and awareness.
Declining or Waning
- Traditional Tuberculosis Studies:
While tuberculosis remains a significant health issue, there has been a noticeable decline in the number of studies solely focused on traditional tuberculosis treatments and diagnostics, as the field has shifted towards addressing multi-drug resistant strains and co-infections. - General Respiratory Infections:
Research on common respiratory infections, such as pneumonia caused by non-specific pathogens, appears to be waning, possibly due to a greater emphasis on more complex or emerging respiratory diseases such as COVID-19 and its sequelae. - Longitudinal Studies on Non-communicable Diseases:
There has been a reduction in longitudinal studies examining the long-term effects of non-communicable respiratory diseases, as the focus has shifted towards acute respiratory conditions and their immediate management. - Pediatric Respiratory Diseases:
The frequency of research focusing specifically on pediatric respiratory diseases has decreased, potentially due to a growing emphasis on adult respiratory conditions and the impact of COVID-19 on adult populations. - Traditional Clinical Trials for Established Therapies:
The journal has seen fewer articles reporting on traditional clinical trials for established therapies, as there is a shift towards exploring novel therapies and personalized medicine in respiratory care.
Similar Journals
CHEST
Empowering healthcare professionals with authoritative research.CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.
Annals of Thoracic Medicine
Unveiling new horizons in cardiology and surgery.Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.
THORAX
Fostering innovation in respiratory disease management.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
Egyptian Journal of Bronchology
Exploring the frontiers of bronchology with every publication.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
EUROPEAN RESPIRATORY JOURNAL
Advancing the Frontiers of Respiratory MedicineThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
Pulmonology
Advancing lung health through groundbreaking research.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
Indian Journal of Respiratory Care
Connecting Experts to Transform Respiratory CareWelcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.
RESPIROLOGY
Exploring New Horizons in Pulmonary MedicineRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
RESPIRATION
Elevating Knowledge in Respiratory HealthRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Pioneering research in respiratory health and intensive care.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.